Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SolastoTSE:6197 58 EV-to-FCF is 17.68 as of Jul. 14, 2026, which is 19% below its 10-year median of 21.85. GuruFocus rates TSE:6197 with a GF Score™ of 58/100 and a GF Value™ of 円564.56 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 404 Healthcare Providers & Services companies, Solasto ranks better than 51.49% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Solasto's Enterprise Value is 円106,506 Mil.
Solasto's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was 円6,025 Mil. Therefore, Solasto's EV-to-FCF for today is 17.68.
The historical rank and industry rank for Solasto's EV-to-FCF or its related term are showing as below:
TSE:6197'
s EV-to-FCF Range Over the Past 10 Years
Min: 7.67 Med: 21.85 Max: 206.74
Current: 17.66
During the past 11 years, the highest EV-to-FCF of Solasto was 206.74. The lowest was 7.67. And the median was 21.85.
TSE:6197's EV-to-FCF is ranked better than 51.49% of 404
companies
in the Healthcare Providers & Services industry
Industry Median: 18.01
vs TSE:6197: 17.66
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
As of today (2026-07-14), Solasto's stock price is 円1111.00.
Solasto's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was 円40.820. Therefore, Solasto's PE Ratio (TTM) for today is 27.22.
Solasto (TSE:6197) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Solasto's share price for today is 円1111.00.
Solasto's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円40.820.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Solasto EV-to-FCF Related Terms
Solasto EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Solasto's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Solasto's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Solasto EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Solasto's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Solasto's EV-to-FCF falls into.
Solasto's current Enterprise Value is 円106,506 Mil.
Solasto's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円6,025 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Solasto (TSE:6197) has a EV-to-FCF of 17.68 as of Jul. 14, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Solasto and its competitors. This is 19% below median its historical median of 21.85. Over the past decade, Solasto's EV-to-FCF has ranged from 7.67 to 206.74. According to the industry distribution chart, Solasto ranks #196 out of 404 companies in the Healthcare Providers & Services industry, placing it in the top 48.5%.
Is Solasto's EV-to-FCF too high?
Solasto's current EV-to-FCF of 17.68 is 19% below median its 10-year median of 21.85. Over the past 10 years, this metric has ranged from a low of 7.67 to a high of 206.74. The Healthcare Providers & Services industry median EV-to-FCF is 18.01. Solasto's value of 17.68 is 1.8% below this industry median. Based on the distribution chart, Solasto ranks #196 out of 404 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Solasto has a GF Score™ of 58/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Solasto's EV-to-FCF compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Solasto ranks #196 out of 404 companies for EV-to-FCF. This puts Solasto in the upper half of its industry. The industry median EV-to-FCF is 18.01. Solasto's value of 17.68 is 1.8% below this benchmark. Historically, Solasto's own EV-to-FCF has ranged from 7.67 to 206.74 over the past decade. While the company's 10-year median is 21.85 vs. the industry median of 18.01, Solasto has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 18.01, based on 404 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Solasto's current EV-to-FCF of 17.68 is 1.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Solasto and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 18.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Solasto's current EV-to-FCF is 17.68, which is 19% below median its own 10-year median of 21.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Solasto stock overvalued right now?
Based on GuruFocus' analysis, Solasto (TSE:6197) is currently considered Significantly Overvalued. The stock's GF Value™ is 円564.56, compared to a current price of 円1,111.00 — trading 96.8% above its estimated fair value. The current EV-to-FCF is 17.68, which is 19% below median its 10-year median of 21.85 and 1.8% below the Healthcare Providers & Services industry median of 18.01. Solasto's overall GF Score™ is 58/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Solasto (TSE:6197), the current EV-to-FCF is 17.68 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Solasto (TSE:6197) Overvalued in 2026?
Based on GuruFocus' analysis, Solasto stock appears to be overvalued.
The current stock price of 円1,111.00 is trading 96.8% above its estimated GF Value™ of 円564.56.
GuruFocus considers Solasto to be Significantly Overvalued.
Key valuation signals for TSE:6197:
EV-to-FCF: 17.68 (19% below median its 10-year median of 21.85)
GF Value™: 円564.56 vs. price of 円1,111.00 (96.8% above fair value)
Industry Position: 1.8% below the Healthcare Providers & Services median (#196 of 404)
No single metric tells the full story. See the TSE:6197 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:6197 has been successfully added to your 
